Advanced Medical Concepts Inc.

NEW N-STORM MICROSCOPE LICENSED FROM HARVARD UNIVERSITY.
Imaging Update; 1/1/2010; 1223 words; ...an innovator of advanced optical instruments...technology is a novel advanced form of optical microscopy...a Howard Hughes Medical Institute Investigator...images. Using this concept, two- and three...Nikon Instruments, Inc. "This level of...NIKON INSTRUMENTS INC. Nikon Instruments...

DATATRAK UNVEILS VERSION 9.0 ECLINCAL SOFTWARE.
GUI Program News; 1/1/2010; 971 words; ...DATATRAK International, Inc. (OTCQX: DATA...tools as well as advanced filtering in existing...DATATRAK International, Inc. DATATRAK International...operate under the concept of DATATRAK ONE...DATATRAK International, Inc.'s product suite...16 drugs and one medical device that have...

Onconova Therapeutics Announces Presentation of Clinical Proof of Concept of ON 01910.Na in Patients with High Risk Myelodysplastic Syndrome MDS at ASH 2009 Annual Meeting.
Blood Weekly; 12/31/2009; 1203 words; ...Onconova Therapeutics, Inc. announced promising...trials in patients with advanced Myelodysplastic Syndrome...Onconova Therapeutics, Inc.). ON 01910.Na is...additional sites, Mt. Sinai Medical Center, Stanford University...Onconova Therapeutics Inc. This article was prepared...

Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin; Collaborative Effort Between Soligenix and Wadsworth Center Describes the Properties of Protective Antibodies to Ricin Toxin.
PR Newswire; 12/28/2009; 2065 words; ...FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board...known as DOR BioPharma, Inc., a late-stage biotechnology...These results advance the concept that antibodies present...toxin and is the most advanced vaccine in the company...of Texas Southwestern Medical Center (UTSW), is...

Neurocrine Advances VMAT2 Inhibitor Program.
PR Newswire; 12/21/2009; 1019 words; ...Neurocrine Biosciences, Inc. today announced...98854, will be advanced in clinical development...O'Brien, Chief Medical Officer of Neurocrine...Phase 2 proof of concept trial to be initiated...Neurocrine Biosciences, Inc. is a biopharmaceutical...Neurocrine Biosciences, Inc. news ...